U.S. Patient Monitoring Market Analysis | 2024-2030

Plastic Optic Fiber Market Report Thumbnail

U.S. Patient Monitoring Market by Product (Cardiac Monitoring Devices, Blood Glucose Monitoring Systems, Hemodynamic/Pressure Monitoring Devices, Multi-parameter Monitoring Devices, Respiratory Monitoring Devices, Temperature Monitoring Devices, Fetal & Neonatal Monitoring Devices, Neuromonitoring Devices, Weight Monitoring Devices, and Other Devices), by Type (Conventional and Wireless), and by End User (Home Healthcare, Hospitals & Clinics, and Others) - Opportunity Analysis and Industry Forecast, 2024–2030

Download PDF

Speak to Our Analyst

Market Definition

The U.S. Patient Monitoring Market size was valued at USD 14.20 billion in 2023, and is predicted to reach USD 23.70 billion by 2030, with a CAGR of 7.3% from 2024 to 2030. Patient monitoring is a critical component of modern medicine, involving the ongoing or regular evaluation of a patient's vital signs, physiological parameters, and general health status throughout their medical care. This process utilizes a variety of medical devices and technologies to gather, record, and analyze data such as blood pressure, heart rate, oxygen saturation, respiratory rate, temperature, and other vital signs.

The patient monitoring market encompasses the healthcare industry segment dedicated to designing, manufacturing, and providing equipment and systems for continuously or intermittently monitoring and recording a patient's vital signs and health parameters. This segment plays a vital role in a variety of healthcare settings, from hospitals and intensive care units to outpatient clinics and home healthcare. This ensures that patients receive the appropriate level of care tailored to their specific medical requirements.

Rising Chronic Disease Fuels Patient Monitoring Demand in the U.S.

The U.S. region is grappling with a surge in chronic diseases, including cardiovascular disorders, diabetes, and respiratory ailments. This escalating health challenge has spurred a heightened demand for patient monitoring solutions. As chronic conditions necessitate continuous supervision, patient monitoring devices have become indispensable tools for healthcare providers. Ranging from wearable sensors to advanced diagnostic equipment, these technologies facilitate real-time tracking of vital signs, early detection of warning signs, and prompt intervention.

Government Initiatives Drives the Growth of Patient Monitoring Devices

The U.S. government plays a crucial role in driving the growth of the patient monitoring market by investing in healthcare infrastructure and promoting the adoption of advanced technologies. Government initiatives often involve providing incentives and creating a favorable regulatory environment to encourage collaboration between the public and private sectors. These efforts aim to improve access to healthcare services, particularly in underserved areas, by deploying mobile health units and telehealth services.
In addition, the government establishes clear regulatory frameworks and conducts public health campaigns to ensure the safe and effective use of patient monitoring technologies while educating the public about the benefits of regular health monitoring.

Connectivity Issues in Patient Monitoring Devices Restrains the Market Growth

One of the significant restraining factors in the patient monitoring market in the U.S. is the connectivity issues which pose a risk to real-time data transmission and communication between devices, impacting the timeliness and accuracy of patient information. Addressing these challenges is crucial for unlocking the full potential of patient monitoring technologies and ensuring their widespread adoption in the healthcare sector.

AI and Machine Learning in Patient Monitoring Systems Creates Ample Growth Opportunities

The emergence of Artificial Intelligence (AI) and Machine Learning (ML) in the U.S. is transforming patient monitoring by enabling the comprehensive analysis of massive datasets. AI algorithms are adept at identifying subtle patterns and anomalies in vital signs and medical history from patient records. This exceptional capability allows for the early detection of potential health issues even before symptoms manifest, paving the way for timely interventions.

Moreover, the integration of AI and ML fosters personalized medicine, enabling treatment plans to be customized to each patient's unique traits and responses. These technologies facilitate risk stratification, assisting healthcare providers in identifying patients at a higher risk of developing specific medical conditions or complications, thereby enabling them to effectively prioritize interventions.

Competitive Landscape

Various market players operating in the U.S. patient monitoring market include Medtronic Plc, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Nihon Kohden Corporation, Abbott Laboratories, Masimo Corporation, Hill-Rom Holdings, Inc., Biotronik SE & Co. KG, Honeywell International, Inc., and others.

U.S. Patient Monitoring Key Market Segments

By Product

Cardiac Monitoring Devices
- Mobile Cardiac Telemetry Monitors
- Electrocardiogram (ECG) Devices
- Implantable Loop Recorders
- Event Monitors
- Smart/Wearable ECG Monitors
Blood Glucose Monitoring Systems
- Self-Monitoring Blood Glucose Systems
- Continuous Glucose Monitoring Systems
Hemodynamic/Pressure Monitoring Devices
- Hemodynamic Monitors
- Blood Pressure Monitors
- Disposables
Multi-Parameter Monitoring Devices
- Low-Acuity Monitoring Device
- Mid-Acuity Monitoring Devices
- High-Acuity Monitoring Devices
Respiratory Monitoring Devices
- Pulse Oximeters
- Spirometers
- Capnographs
- Peak Flow Meters
Temperature Monitoring Device
- Handheld Temperature Monitoring Devices
- Table-Top Temperature Monitoring Devices
- Wearable Continuous Monitoring Devices
- Invasive Temperature Monitoring Devices
- Smart Temperature Monitoring Devices
Fetal & Neonatal Monitoring Devices
- Neonatal Monitoring Devices
- Fetal Monitoring Devices
Neuromonitoring Devices
- Electroencephalograph (EEG) Machines
- Electromyography Machines
- Cerebral Oximeter
- Intracranial Pressure (ICP) Monitors
- Magnetoencephalography (MEG) Machines
- Transcranial Doppler (TCD) Machines
Weight Monitoring Devices
- Digital
- Analog
Others Devices

By Type

Conventional
Wireless

By End User

Home Healthcare
Hospitals & Clinics
Others

REPORT SCOPE AND SEGMENTATION:

Parameters	Details
Market Size in 2023	USD 14.20 Billion
Revenue Forecast in 2030	USD 23.70 Billion
Revenue Growth Rate	CAGR of 7.3% from 2024 to 2030
Analysis Period	2023–2030
Base Year Considered	2023
Forecast Period	2024–2030
Market Size Estimation	Billion (USD)
Growth Factors	Rising Chronic Disease Fuels Patient Monitoring Demand in the U.S. Government Initiatives Drives the Growth of Patient Monitoring Devices
Companies Profiled	10
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.

KEY PLAYERS

Medtronic Plc
Koninklijke Philips N.V.
GE Healthcare
Siemens Healthineers
Nihon Kohden Corporation
Abbott Laboratories
Masimo Corporation
Hill-Rom Holdings, Inc.
Biotronik SE & Co. KG
Honeywell International, Inc.

1 INTRODUCTION

1.1 REPORT DESCRIPTION

1.2 RESEARCH METHODOLOGY

1.2.1 SECONDARY RESEARCH

1.2.2 DATA ANALYSIS FRAMEWORK

1.2.3 MARKET SIZE ESTIMATION

1.2.4 FORECASTING

1.2.5 PRIMARY RESEARCH AND DATA VALIDATION

2 U.S. PATIENT MONITORING MARKET – EXECUTIVE SUMMARY

2.1. MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3 PORTER’S FIVE FORCE MODEL ANALYSIS

3.1 BARGAINING POWER OF SUPPLIERS

3.2 BARGAINING POWER OF BUYERS

3.3 DEGREE OF COMPETITION

3.4 THREAT OF SUBSTITUTE

3.5 THREAT OF NEW ENTRANTS

4 MARKET SHARE ANALYSIS

4.1 MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5 MARKET DYNAMICS

5.1 GROWTH DRIVERS

5.1.1 DRIVER 1

5.1.2 DRIVER 2

5.1.3 DRIVER 3

5.1.4 DRIVER 4

5.2 CHALLENGES

5.2.1 CHALLENGE 1

5.2.2 CHALLENGE 2

5.2.3 CHALLENGE 3

5.2.4 CHALLENGE 4

5.3 OPPORTUNITIES

5.3.1 OPPORTUNITY 1

5.3.2 OPPORTUNITY 2

6 U.S. PATIENT MONITORING MARKET BY PRODUCT

6.1 OVERVIEW

6.2 CARDIAC MONITORING DEVICES MARKET

6.2.1 MOBILE CARDIAC TELEMETRY MONITORS

6.2.2 ELECTROCARDIOGRAM (ECG) DEVICES

6.2.3 IMPLANTABLE LOOP RECORDERS

6.2.4 EVENT MONITORS

6.2.5 SMART/WEARABLE ECG MONITORS

6.3 BLOOD GLUCOSE MONITORING SYSTEMS MARKET

6.3.1 SELF-MONITORING BLOOD GLUCOSE SYSTEMS

6.3.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS

6.4 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET

6.4.1 HEMODYNAMIC MONITORS

6.4.2 BLOOD PRESSURE MONITORS

6.4.3 DISPOSABLES

6.5 MULTI-PARAMETER MONITORING DEVICES MARKET

6.5.1 LOW-ACUITY MONITORING DEVICE

6.5.2 MID-ACUITY MONITORING DEVICES

6.5.3 HIGH-ACUITY MONITORING DEVICES

6.6 RESPIRATORY MONITORING DEVICES MARKET

6.6.1 PULSE OXIMETERS

6.6.2 SPIROMETERS

6.6.3 CAPNOGRAPHS

6.6.4 PEAK FLOW METERS

6.7 TEMPERATURE MONITORING DEVICE MARKET

6.7.1 HANDHELD TEMPERATURE MONITORING DEVICES

6.7.2 TABLE-TOP TEMPERATURE MONITORING DEVICES

6.7.3 WEARABLE CONTINUOUS MONITORING DEVICES

6.7.4 INVASIVE TEMPERATURE MONITORING DEVICES

6.7.5 SMART TEMPERATURE MONITORING DEVICES

6.8 FETAL AND NEONATAL MONITORING DEVICES MARKET

6.8.1 NEONATAL MONITORING DEVICES

6.8.2 FETAL MONITORING DEVICES

6.9 NEUROMONITORING DEVICES MARKET

6.9.1 ELECTROENCEPHALOGRAPH (EEG) MACHINES

6.9.2 ELECTROMYOGRAPHY MACHINES

6.9.3 CEREBRAL OXIMETER

6.9.4 INTRACRANIAL PRESSURE (ICP) MONITORS

6.9.5 MAGNETOENCEPHALOGRAPHY (MEG) MACHINES

6.9.6 TRANSCRANIAL DOPPLER (TCD) MACHINES

6.10 WEIGHT MONITORING DEVICES MARKET

6.10.1 DIGITAL

6.10.2 ANALOG

6.11 OTHERS DEVICES MARKET

7 U.S. PATIENT MONITORING MARKET BY TYPE

7.1 OVERVIEW

7.2 CONVENTIONAL MARKET

7.3 WIRELESS MARKET

8 U.S. PATIENT MONITORING MARKET BY END USER

8.1 OVERVIEW

8.2 HOME HEALTHCARE MARKET

8.3 HOSPITALS AND CLINICS MARKET

8.4 OTHERS MARKET

9 COMPANY PROFILES

9.1 MEDTRONIC PLC

9.1.1 COMPANY OVERVIEW

9.1.2 COMPANY SNAPSHOT

9.1.3 OPERATING BUSINESS SEGMENTS

9.1.4 PRODUCT PORTFOLIO

9.1.5 BUSINESS PERFORMANCE

9.1.6 BUSINESS SEGMENTS

9.1.7 GEOGRAPHIC SEGMENTS

9.1.8 KEY STRATEGIC MOVES AND DEVELOPMENT

9.1.9 PRIMARY MARKET COMPETITORS

9.2 KONINKLIJKE PHILIPS N.V.

9.2.1 COMPANY OVERVIEW

9.2.2 COMPANY SNAPSHOT

9.2.3 OPERATING BUSINESS SEGMENTS

9.2.4 PRODUCT PORTFOLIO

9.2.5 BUSINESS PERFORMANCE

9.2.6 BUSINESS SEGMENTS

9.2.7 GEOGRAPHIC SEGMENTS

9.2.8 KEY STRATEGIC MOVES AND DEVELOPMENT

9.2.9 PRIMARY MARKET COMPETITORS

9.3 GE HEALTHCARE

9.3.1 COMPANY OVERVIEW

9.3.2 COMPANY SNAPSHOT

9.3.3 OPERATING BUSINESS SEGMENTS

9.3.4 PRODUCT PORTFOLIO

9.3.5 BUSINESS PERFORMANCE

9.3.6 BUSINESS SEGMENTS

9.3.7 GEOGRAPHIC SEGMENTS

9.3.8 KEY STRATEGIC MOVES AND DEVELOPMENT

9.3.9 PRIMARY MARKET COMPETITORS

9.4 SIEMENS HEALTHINEERS

9.4.1 COMPANY OVERVIEW

9.4.2 COMPANY SNAPSHOT

9.4.3 OPERATING BUSINESS SEGMENTS

9.4.4 PRODUCT PORTFOLIO

9.4.5 BUSINESS PERFORMANCE

9.4.6 BUSINESS SEGMENTS

9.4.7 GEOGRAPHIC SEGMENTS

9.4.8 KEY STRATEGIC MOVES AND DEVELOPMENT

9.4.9 PRIMARY MARKET COMPETITORS

9.5 NIHON KOHDEN CORPORATION

9.5.1 COMPANY OVERVIEW

9.5.2 COMPANY SNAPSHOT

9.5.3 OPERATING BUSINESS SEGMENTS

9.5.4 PRODUCT PORTFOLIO

9.5.5 BUSINESS PERFORMANCE

9.5.6 BUSINESS SEGMENTS

9.5.7 GEOGRAPHIC SEGMENTS

9.5.8 KEY STRATEGIC MOVES AND DEVELOPMENT

9.5.9 PRIMARY MARKET COMPETITORS

9.6 ABBOTT LABORATORIES

9.6.1 COMPANY OVERVIEW

9.6.2 COMPANY SNAPSHOT

9.6.3 OPERATING BUSINESS SEGMENTS

9.6.4 PRODUCT PORTFOLIO

9.6.5 BUSINESS PERFORMANCE

9.6.6 BUSINESS SEGMENTS

9.6.7 GEOGRAPHIC SEGMENTS

9.6.8 KEY STRATEGIC MOVES AND DEVELOPMENT

9.6.9 PRIMARY MARKET COMPETITORS

9.7 MASIMO CORPORATION

9.7.1 COMPANY OVERVIEW

9.7.2 COMPANY SNAPSHOT

9.7.3 OPERATING BUSINESS SEGMENTS

9.7.4 PRODUCT PORTFOLIO

9.7.5 BUSINESS PERFORMANCE

9.7.6 BUSINESS SEGMENTS

9.7.7 GEOGRAPHIC SEGMENTS

9.7.8 KEY STRATEGIC MOVES AND DEVELOPMENT

9.7.9 PRIMARY MARKET COMPETITORS

9.8 HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG

9.8.1 COMPANY OVERVIEW

9.8.2 COMPANY SNAPSHOT

9.8.3 OPERATING BUSINESS SEGMENTS

9.8.4 PRODUCT PORTFOLIO

9.8.5 BUSINESS PERFORMANCE

9.8.6 BUSINESS SEGMENTS

9.8.7 GEOGRAPHIC SEGMENTS

9.8.8 KEY STRATEGIC MOVES AND DEVELOPMENT

9.8.9 PRIMARY MARKET COMPETITORS

9.9 BIOTRONIK SE AND CO. KG

9.9.1 COMPANY OVERVIEW

9.9.2 COMPANY SNAPSHOT

9.9.3 OPERATING BUSINESS SEGMENTS

9.9.4 PRODUCT PORTFOLIO

9.9.5 BUSINESS PERFORMANCE

9.9.6 BUSINESS SEGMENTS

9.9.7 GEOGRAPHIC SEGMENTS

9.9.8 KEY STRATEGIC MOVES AND DEVELOPMENT

9.9.9 PRIMARY MARKET COMPETITORS

9.10 HONEYWELL INTERNATIONAL, INC.

9.10.1 COMPANY OVERVIEW

9.10.2 COMPANY SNAPSHOT

9.10.3 OPERATING BUSINESS SEGMENTS

9.10.4 PRODUCT PORTFOLIO

9.10.5 BUSINESS PERFORMANCE

9.10.6 BUSINESS SEGMENTS

9.10.7 GEOGRAPHIC SEGMENTS

9.10.8 KEY STRATEGIC MOVES AND DEVELOPMENT

9.10.9 PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. U.S. PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 2. CARDIAC MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 3. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 4. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 5. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 6. EVENT MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 7. SMART/WEARABLE ECG MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 8. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 9. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 10. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 11. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 12. HEMODYNAMIC MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 13. BLOOD PRESSURE MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 14. DISPOSABLES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 15. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 16. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 17. MID-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 18. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 19. RESPIRATORY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 20. PULSE OXIMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 21. SPIROMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 22. CAPNOGRAPHS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 23. PEAK FLOW METERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 24. TEMPERATURE MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 25. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 26. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 27. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 28. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 29. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 30. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 31. NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 32. FETAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 33. NEUROMONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 34. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 35. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 36. CEREBRAL OXIMETER, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 37. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 38. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 39. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 40. WEIGHT MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 41. DIGITAL, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 42. ANALOG, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 43. OTHERS DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 44. U.S. PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 45. CONVENTIONAL, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 46. WIRELESS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 47. U.S. PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 48. HOME HEALTHCARE, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 49. HOSPITALS AND CLINICS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 50. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 51. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 52. MEDTRONIC PLC: OPERATING BUSINESS SEGMENTS

TABLE 53. MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 54. MEDTRONIC PLC: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 55. MEDTRONIC PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 56. MEDTRONIC PLC: KEY STRATERGY

TABLE 57. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 58. KONINKLIJKE PHILIPS N.V.: OPERATING BUSINESS SEGMENTS

TABLE 59. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 60. KONINKLIJKE PHILIPS N.V.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 61. KONINKLIJKE PHILIPS N.V.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 62. KONINKLIJKE PHILIPS N.V.: KEY STRATERGY

TABLE 63. GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 64. GE HEALTHCARE: OPERATING BUSINESS SEGMENTS

TABLE 65. GE HEALTHCARE: PRODUCT PORTFOLIO

TABLE 66. GE HEALTHCARE: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 67. GE HEALTHCARE: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 68. GE HEALTHCARE: KEY STRATERGY

TABLE 69. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT

TABLE 70. SIEMENS HEALTHINEERS: OPERATING BUSINESS SEGMENTS

TABLE 71. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO

TABLE 72. SIEMENS HEALTHINEERS: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 73. SIEMENS HEALTHINEERS: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 74. SIEMENS HEALTHINEERS: KEY STRATERGY

TABLE 75. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 76. NIHON KOHDEN CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 77. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO

TABLE 78. NIHON KOHDEN CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 79. NIHON KOHDEN CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 80. NIHON KOHDEN CORPORATION: KEY STRATERGY

TABLE 81. ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 82. ABBOTT LABORATORIES: OPERATING BUSINESS SEGMENTS

TABLE 83. ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 84. ABBOTT LABORATORIES: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 85. ABBOTT LABORATORIES: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 86. ABBOTT LABORATORIES: KEY STRATERGY

TABLE 87. MASIMO CORPORATION: COMPANY SNAPSHOT

TABLE 88. MASIMO CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 89. MASIMO CORPORATION: PRODUCT PORTFOLIO

TABLE 90. MASIMO CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 91. MASIMO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 92. MASIMO CORPORATION: KEY STRATERGY

TABLE 93. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT

TABLE 94. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: OPERATING BUSINESS SEGMENTS

TABLE 95. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO

TABLE 96. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 97. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 98. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: KEY STRATERGY

TABLE 99. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT

TABLE 100. BIOTRONIK SE AND CO. KG: OPERATING BUSINESS SEGMENTS

TABLE 101. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO

TABLE 102. BIOTRONIK SE AND CO. KG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 103. BIOTRONIK SE AND CO. KG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 104. BIOTRONIK SE AND CO. KG: KEY STRATERGY

TABLE 105. HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT

TABLE 106. HONEYWELL INTERNATIONAL, INC.: OPERATING BUSINESS SEGMENTS

TABLE 107. HONEYWELL INTERNATIONAL, INC.: PRODUCT PORTFOLIO

TABLE 108. HONEYWELL INTERNATIONAL, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 109. HONEYWELL INTERNATIONAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 110. HONEYWELL INTERNATIONAL, INC.: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. U.S. PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

FIGURE 7. CARDIAC MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 8. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 9. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 10. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 11. EVENT MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 12. SMART/WEARABLE ECG MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 13. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 14. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 15. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 16. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 17. HEMODYNAMIC MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 18. BLOOD PRESSURE MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 19. DISPOSABLES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 20. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 21. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 22. MID-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 23. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 24. RESPIRATORY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 25. PULSE OXIMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 26. SPIROMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 27. CAPNOGRAPHS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 28. PEAK FLOW METERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 29. TEMPERATURE MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 30. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 31. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 32. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 33. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 34. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 35. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 36. NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 37. FETAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 38. NEUROMONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 39. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 40. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 41. CEREBRAL OXIMETER, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 42. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 43. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 44. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 45. WEIGHT MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 46. DIGITAL, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 47. ANALOG, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 48. OTHERS DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 49. U.S. PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

FIGURE 50. CONVENTIONAL, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 51. WIRELESS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 52. U.S. PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

FIGURE 53. HOME HEALTHCARE, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 54. HOSPITALS AND CLINICS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 55. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 56. MEDTRONIC PLC: NET SALES, (2021-2023)

FIGURE 57. MEDTRONIC PLC: PRIMARY MARKET COMPETITORS

FIGURE 58. KONINKLIJKE PHILIPS N.V.: NET SALES, (2021-2023)

FIGURE 59. KONINKLIJKE PHILIPS N.V.: PRIMARY MARKET COMPETITORS

FIGURE 60. GE HEALTHCARE: NET SALES, (2021-2023)

FIGURE 61. GE HEALTHCARE: PRIMARY MARKET COMPETITORS

FIGURE 62. SIEMENS HEALTHINEERS: NET SALES, (2021-2023)

FIGURE 63. SIEMENS HEALTHINEERS: PRIMARY MARKET COMPETITORS

FIGURE 64. NIHON KOHDEN CORPORATION: NET SALES, (2021-2023)

FIGURE 65. NIHON KOHDEN CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 66. ABBOTT LABORATORIES: NET SALES, (2021-2023)

FIGURE 67. ABBOTT LABORATORIES: PRIMARY MARKET COMPETITORS

FIGURE 68. MASIMO CORPORATION: NET SALES, (2021-2023)

FIGURE 69. MASIMO CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 70. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: NET SALES, (2021-2023)

FIGURE 71. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: PRIMARY MARKET COMPETITORS

FIGURE 72. BIOTRONIK SE AND CO. KG: NET SALES, (2021-2023)

FIGURE 73. BIOTRONIK SE AND CO. KG: PRIMARY MARKET COMPETITORS

FIGURE 74. HONEYWELL INTERNATIONAL, INC.: NET SALES, (2021-2023)

FIGURE 75. HONEYWELL INTERNATIONAL, INC.: PRIMARY MARKET COMPETITORS

Frequently Asked Questions

According to Next Move Strategy Consulting, the market size of the U.S. patient monitoring will be USD 23.70 billion in 2030.

According to Next Move Strategy Consulting, the market size of the U.S. patient monitoring is USD 14.20 billion in 2023.

AI is used to analyze large datasets from patient monitoring devices, helping healthcare providers detect trends and anomalies and predict patient outcomes effectively.

Wearable patient monitoring devices offer real-time data, improved patient comfort, and the ability to track health metrics continuously, which can aid in early disease detection and management.

The top companies operating in the patient monitoring market include Medtronic Plc, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, and Abbott Laboratories.

Download Free Sample

Yes, I have read the Privacy Policy

Multi User

$2,575

Single User

$1,525

Enterprise

$3,874

Datapack

$2,975

Our Clients

View All

Features
	Single User	Multi User	Enterprise User	Data Pack
	US $ 1,525	US $ 2,575	US $ 3,874	US $ 2,975
	1 user only	1 user only	Unlimited access within the Organization	1 user only

Free Customization	20 hours	40 hours	>60 hours	NA
Duration Of Free Analyst Support	3 months post purchase	6 months post purchase	12 months post purchase	NA
Direct Access to the Analyst Team Through Calls / Email
Deliverable Format
Deliverable Format
Discount on Your Next Purchase	No Discount	15%	No Discount	No Discount
Permission to Print the Report